13-113667525-TGTGA-T
Position:
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PVS1PM2PP5
The NM_002929.3(GRK1):c.142_145del(p.Glu48ProfsTer82) variant causes a frameshift change. The variant allele was found at a frequency of 0.00000821 in 1,461,082 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (no stars). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000082 ( 0 hom. )
Consequence
GRK1
NM_002929.3 frameshift
NM_002929.3 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 6.27
Genes affected
GRK1 (HGNC:10013): (G protein-coupled receptor kinase 1) This gene encodes a member of the guanine nucleotide-binding protein (G protein)-coupled receptor kinase subfamily of the Ser/Thr protein kinase family. The protein phosphorylates rhodopsin and initiates its deactivation. Defects in GRK1 are known to cause Oguchi disease 2 (also known as stationary night blindness Oguchi type-2). [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 11 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 13-113667525-TGTGA-T is Pathogenic according to our data. Variant chr13-113667525-TGTGA-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 870427.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr13-113667525-TGTGA-T is described in Lovd as [Likely_pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GRK1 | NM_002929.3 | c.142_145del | p.Glu48ProfsTer82 | frameshift_variant | 1/7 | ENST00000335678.7 | |
GRK1 | XM_047430493.1 | c.-6-2159_-6-2156del | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GRK1 | ENST00000335678.7 | c.142_145del | p.Glu48ProfsTer82 | frameshift_variant | 1/7 | 1 | NM_002929.3 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD3 exomes AF: 0.0000242 AC: 6AN: 248384Hom.: 0 AF XY: 0.0000296 AC XY: 4AN XY: 134928
GnomAD3 exomes
AF:
AC:
6
AN:
248384
Hom.:
AF XY:
AC XY:
4
AN XY:
134928
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000821 AC: 12AN: 1461082Hom.: 0 AF XY: 0.0000124 AC XY: 9AN XY: 726814
GnomAD4 exome
AF:
AC:
12
AN:
1461082
Hom.:
AF XY:
AC XY:
9
AN XY:
726814
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Likely pathogenic
Submissions summary: Pathogenic:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
Oguchi disease-2 Pathogenic:1
Likely pathogenic, no assertion criteria provided | clinical testing | Molecular Medicine, University of Leeds | Feb 20, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at